Health Innovation Capital ('HIC') is a venture capital impact fund that invests in disruptive healthcare innovation that addresses the unmet medical needs of pediatric patients within Oncology, Infectious Diseases, and select Rare and Orphan Designations. HIC is a tenured, diverse, and cohesive team of venture investors and medical innovation executives who have worked together to finance and advance some of the healthcare industry’s most important technological and service advancements. This unique team possesses a track record that encompasses over 125 years collectively of achieving significant exits and venture returns within HIC’s target indications and health sectors. Coupled with HIC’s scientific and medical advisors, who are leading physicians, C-suite executives, and researchers, the firm is a recognized thought leader and enabler in advancing innovative solutions across a pediatric patient's journey from prevention and diagnosis to treatment and ongoing care. Our commitment to support the advancement of pediatric health innovation is reinforced via the creation of the HIC Foundation - which donates 10% of the fund’s General Partner Carry Interest to renowned centers of pediatric care.